Search results
Results from the Tech24 Deals Content Network
At recent prices, you can scoop up shares of Bristol Myers Squibb for about 8.3 times trailing free cash flow. This multiple is so low that long-term investors could realize market-beating gains ...
Friday, Bristol Myers Squibb & Co (NYSE:BMY) posted second-quarter revenues of $12.20 billion, beating the consensus of $11.55 billion, an increase of 9% year-over-year, or 11% when adjusted for ...
Bristol-Myers Squibb (BMY) closed at $60.50 in the latest trading session, marking a -1.59% move from the prior day.
The Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb ( BMS ), is an American multinational pharmaceutical company. Headquartered in Princeton, New Jersey, [ 2] BMS is one of the world's largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations.
In April 2007, The Wall Street Journal reported that "Bristol-Myers Squibb Co. and ImClone Systems Inc. said their cancer drug, Erbitux, failed to significantly prolong the lives of people with pancreatic cancer in a new study, marking yet another setback in the drug industry's efforts to find a better treatment for this deadly disease."
Bristol Myers Squibb: A high-yield dividend stock with an attractive valuation. Bristol Myers Squibb, or BMS for short, is another well-established pharmaceutical company with a strong presence in ...
Bristol-Myers (BMY) has seen solid earnings estimate revision activity over the past month, ... News. 24/7 help. For premium support please call: 800-290-4726 more ways to reach us. Login / Join.
In the latest trading session, Bristol-Myers Squibb (BMY) closed at $63.50, marking a -0.5% move from the previous day.